technetium tc 99m sestamibi has been researched along with Adrenal Cortex Cancer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balasubramanian, SP; Debono, M; Edafe, O; Tahir, F | 1 |
Calvieri, C; Catani, M; Letizia, C; Marinelli, C; Petramala, L; Savoriti, C; Settevendemmie, A; Zinnamosca, L | 1 |
Arai, T; Araki, T; Arbab, AS; Koizumi, K; Toyama, K | 1 |
3 other study(ies) available for technetium tc 99m sestamibi and Adrenal Cortex Cancer
Article | Year |
---|---|
Simultaneous presentation of parathyroid carcinoma, papillary thyroid cancer and ACTH-independent hypercortisolism due to benign cortical adenoma.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Adenoma; Carcinoma; Cushing Syndrome; Female; Humans; Hyperparathyroidism, Primary; Microscopy, Acoustic; Middle Aged; Neoplasms, Multiple Primary; Parathyroid Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thyroid Cancer, Papillary; Thyroid Neoplasms; Tomography, X-Ray Computed | 2019 |
Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders.
Topics: Adrenal Cortex Neoplasms; Adrenalectomy; Adrenocortical Adenoma; Adult; Arrhythmias, Cardiac; Electrocardiography; Felodipine; Female; Humans; Hyperaldosteronism; Hypercalcemia; Hyperparathyroidism, Primary; Hypokalemia; Magnetic Resonance Imaging; Potassium Chloride; Radiopharmaceuticals; Spironolactone; Technetium Tc 99m Sestamibi | 2013 |
Effects of ion channel modulators in the influx and efflux of Tc-99m-MIBI.
Topics: Adrenal Cortex Neoplasms; Amiloride; Calcium; Calcium Channel Blockers; Calcium Channels; Carcinoma, Small Cell; Flunarizine; Humans; Monensin; Sodium; Sodium Channels; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured; Verapamil | 1999 |